Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up.

Guray SaydamIbrahim Celalettin HaznedarogluLeylagul KaynarAkif S YavuzRidvan AliBirol GuvencOlga M AkayZafer BaslarUgur OzbekMehmet SonmezDemet AydinMustafa PehlivanBulent UndarSimten DagdasOrhan AyyildizGülnur AkinIlkiz M DagOsman Ilhan

Published in: Hematology (Amsterdam, Netherlands) (2018)

Frontline nilotinib treatment provided sustained efficacy, with good tolerability, over 24 months in newly diagnosed CML-CP patients.

Keyphrases

chronic myeloid leukemia
newly diagnosed
end stage renal disease
ejection fraction
acute lymphoblastic leukemia
randomized controlled trial
chronic kidney disease
gene expression
peritoneal dialysis
prognostic factors
patient reported outcomes
copy number
double blind
placebo controlled